{"id":"W4281678979","doi":"10.1200/jco.2022.40.16_suppl.tps7583","title":"inMIND: A phase 3 study of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab for relapsed/refractory follicular or marginal zone lymphoma.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Lenalidomide; Follicular lymphoma; Internal medicine; Phases of clinical research; Oncology; CD20; Lymphoma; Clinical trial; Gastroenterology; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001899677,0.002279824,0.002784306,0.0007252065,0.0005220056,0.001458832,0.001958088,0.001740745,0.009585041],"category_scores_gemma":[0.001000623,0.0009677555,0.002223267,0.0004668238,0.001257246,0.001374342,0.0005972796,0.004873537,0.002179017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001305028,"about_ca_system_score_gemma":0.001977359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00127725,"about_ca_topic_score_gemma":0.003690014,"domain_scores_codex":[0.999526,0.000225803,0.0000186432,0.00007921466,0.00004753,0.0001028689],"domain_scores_gemma":[0.9994387,0.00008575172,0.0001075113,0.00004266349,0.0000408915,0.0002845216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8826426,0.05320389,0.0009522835,0.0008160524,0.001248937,0.0001096346,0.0001396014,0.0007833584,0.01337245,0.0002301763,0.00317571,0.04332531],"study_design_scores_gemma":[0.8091897,0.1840858,0.002307633,0.00004420465,0.0004769961,0.0001145028,0.00005121295,0.0004437487,0.001086296,0.0001775298,0.001999098,0.0000232154],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9710528,0.006859852,0.00122656,0.001488795,0.000671407,0.008686375,0.003704999,0.0005820301,0.00572719],"genre_scores_gemma":[0.9614202,0.005303266,0.004558841,0.002432126,0.0005039859,0.01103186,0.005331127,0.0001204938,0.009298092],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009585041,"threshold_uncertainty_score":0.03206521,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1266544369970282,"score_gpt":0.451538070324499,"score_spread":0.3248836333274708,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}